Literature DB >> 29357496

Altered skeletal muscle mitochondrial phenotype in COPD: disease vs. disuse.

Jayson R Gifford1,2,3, Joel D Trinity2,3, Oh-Sung Kwon2,3, Gwenael Layec2,3, Ryan S Garten4, Song-Young Park5, Ashley D Nelson2,3, Russell S Richardson2,3,6.   

Abstract

Patients with chronic obstructive pulmonary disease (COPD) exhibit an altered skeletal muscle mitochondrial phenotype, which often includes reduced mitochondrial density, altered respiratory function, and elevated oxidative stress. As this phenotype may be explained by the sedentary lifestyle that commonly accompanies this disease, the aim of this study was to determine whether such alterations are still evident when patients with COPD are compared to control subjects matched for objectively measured physical activity (PA; accelerometry). Indexes of mitochondrial density [citrate synthase (CS) activity], respiratory function (respirometry in permeabilized fibers), and muscle oxidative stress [4-hydroxynonenal (4-HNE) content] were assessed in muscle fibers biopsied from the vastus lateralis of nine patients with COPD and nine PA-matched control subjects (CON). Despite performing similar levels of PA (CON: 18 ± 3, COPD: 20 ± 7 daily minutes moderate-to-vigorous PA; CON: 4,596 ± 683, COPD: 4,219 ± 763 steps per day, P > 0.70), patients with COPD still exhibited several alterations in their mitochondrial phenotype, including attenuated skeletal muscle mitochondrial density (CS activity; CON 70.6 ± 3.8, COPD 52.7 ± 6.5 U/mg, P < 0.05), altered mitochondrial respiration [e.g., ratio of complex I-driven state 3 to complex II-driven state 3 (CI/CII); CON: 1.20 ± 0.11, COPD: 0.90 ± 0.05, P < 0.05), and oxidative stress (4-HNE; CON: 1.35 ± 0.19, COPD: 2.26 ± 0.25 relative to β-actin, P < 0.05). Furthermore, CS activity ( r = 0.55), CI/CII ( r = 0.60), and 4-HNE ( r = 0.49) were all correlated with pulmonary function, assessed as forced expiratory volume in 1 s ( P < 0.05), but not PA ( P > 0.05). In conclusion, the altered mitochondrial phenotype in COPD is present even in the absence of differing levels of PA and appears to be related to the disease itself. NEW &amp; NOTEWORTHY Chronic obstructive pulmonary disease (COPD) is associated with debilitating alterations in the function of skeletal muscle mitochondria. By comparing the mitochondrial phenotype of patients with COPD to that of healthy control subjects who perform the same amount of physical activity each day, this study provides evidence that many aspects of the dysfunctional mitochondrial phenotype observed in COPD are not merely due to reduced physical activity but are likely related to the disease itself.

Entities:  

Keywords:  COPD; mitochondrial dysfunction; muscle dysfunction; physical activity

Mesh:

Year:  2017        PMID: 29357496      PMCID: PMC5972462          DOI: 10.1152/japplphysiol.00788.2017

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  40 in total

Review 1.  From muscle disuse to myopathy in COPD: potential contribution of oxidative stress.

Authors:  A Couillard; C Prefaut
Journal:  Eur Respir J       Date:  2005-10       Impact factor: 16.671

2.  Time course of loss of adaptations after stopping prolonged intense endurance training.

Authors:  E F Coyle; W H Martin; D R Sinacore; M J Joyner; J M Hagberg; J O Holloszy
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1984-12

Review 3.  Adaptations of skeletal muscle to endurance exercise and their metabolic consequences.

Authors:  J O Holloszy; E F Coyle
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1984-04

4.  Characteristics of physical activities in daily life in chronic obstructive pulmonary disease.

Authors:  Fabio Pitta; Thierry Troosters; Martijn A Spruit; Vanessa S Probst; Marc Decramer; Rik Gosselink
Journal:  Am J Respir Crit Care Med       Date:  2005-01-21       Impact factor: 21.405

5.  Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease.

Authors:  F Maltais; P LeBlanc; C Simard; J Jobin; C Bérubé; J Bruneau; L Carrier; R Belleau
Journal:  Am J Respir Crit Care Med       Date:  1996-08       Impact factor: 21.405

6.  Skeletal muscle mitochondrial H2 O2 emission increases with immobilization and decreases after aerobic training in young and older men.

Authors:  Martin Gram; Andreas Vigelsø; Takashi Yokota; Jørn Wulff Helge; Flemming Dela; Martin Hey-Mogensen
Journal:  J Physiol       Date:  2015-07-27       Impact factor: 5.182

7.  Oxygen delivery-utilization mismatch in contracting locomotor muscle in COPD: peripheral factors.

Authors:  Wladimir M Medeiros; Mari C T Fernandes; Diogo P Azevedo; Flavia F M de Freitas; Beatriz C Amorim; Luciana D Chiavegato; Daniel M Hirai; Denis E O'Donnell; J Alberto Neder
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-12-04       Impact factor: 3.619

8.  Symmorphosis and skeletal muscle V̇O2 max : in vivo and in vitro measures reveal differing constraints in the exercise-trained and untrained human.

Authors:  Jayson R Gifford; Ryan S Garten; Ashley D Nelson; Joel D Trinity; Gwenael Layec; Melissa A H Witman; Joshua C Weavil; Tyler Mangum; Corey Hart; Cory Etheredge; Jake Jessop; Amber Bledsoe; David E Morgan; D Walter Wray; Matthew J Rossman; Russell S Richardson
Journal:  J Physiol       Date:  2016-01-19       Impact factor: 5.182

Review 9.  Metabolic derangements in COPD muscle dysfunction.

Authors:  Luis Puente-Maestu; Alberto Lázaro; Blanca Humanes
Journal:  J Appl Physiol (1985)       Date:  2013-01-03

Review 10.  Mitochondria and reactive oxygen species.

Authors:  Alicia J Kowaltowski; Nadja C de Souza-Pinto; Roger F Castilho; Anibal E Vercesi
Journal:  Free Radic Biol Med       Date:  2009-05-08       Impact factor: 7.376

View more
  8 in total

1.  Determinants of the diminished exercise capacity in patients with chronic obstructive pulmonary disease: looking beyond the lungs.

Authors:  Ryan M Broxterman; Jan Hoff; Peter D Wagner; Russell S Richardson
Journal:  J Physiol       Date:  2020-01-19       Impact factor: 5.182

Review 2.  Measuring and monitoring skeletal muscle function in COPD: current perspectives.

Authors:  Sarah Marklund; Kim-Ly Bui; Andre Nyberg
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-08-19

3.  Mitochondrial dysfunction in airways and quadriceps muscle of patients with chronic obstructive pulmonary disease.

Authors:  Gulam Haji; Coen H Wiegman; Charalambos Michaeloudes; Mehul S Patel; Katrina Curtis; Pankaj Bhavsar; Michael I Polkey; Ian M Adcock; Kian Fan Chung
Journal:  Respir Res       Date:  2020-10-12

4.  Ninjin'yoeito Ameliorates Skeletal Muscle Complications in COPD Model Mice by Upregulating Peroxisome Proliferator-Activated Receptor γ Coactivator-1α Expression.

Authors:  Atsushi Miyamoto; Kazuhisa Asai; Hideaki Kadotani; Naomi Maruyama; Hiroaki Kubo; Atsuko Okamoto; Kanako Sato; Kazuhiro Yamada; Naoki Ijiri; Tetsuya Watanabe; Tomoya Kawaguchi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-11-27

5.  Response to Electrostimulation Is Impaired in Muscle Cells from Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Matthias Catteau; Emilie Passerieux; Léo Blervaque; Farés Gouzi; Bronia Ayoub; Maurice Hayot; Pascal Pomiès
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

6.  Molecular signalling towards mitochondrial breakdown is enhanced in skeletal muscle of patients with chronic obstructive pulmonary disease (COPD).

Authors:  P A Leermakers; A M W J Schols; A E M Kneppers; M C J M Kelders; C C de Theije; M Lainscak; H R Gosker
Journal:  Sci Rep       Date:  2018-10-09       Impact factor: 4.379

7.  Role of inner mitochondrial protein OPA1 in mitochondrial dysfunction by tobacco smoking and in the pathogenesis of COPD.

Authors:  Krishna Prahlad Maremanda; Isaac Kirubakaran Sundar; Irfan Rahman
Journal:  Redox Biol       Date:  2021-06-24       Impact factor: 11.799

8.  NMR Spectroscopy Identifies Chemicals in Cigarette Smoke Condensate That Impair Skeletal Muscle Mitochondrial Function.

Authors:  Ram B Khattri; Trace Thome; Liam F Fitzgerald; Stephanie E Wohlgemuth; Russell T Hepple; Terence E Ryan
Journal:  Toxics       Date:  2022-03-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.